NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 918 filers reported holding NOVARTIS A G in Q3 2015. The put-call ratio across all filers is 1.29 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $508,000 | +100.0% | 7,014 | +137.8% | 0.05% | +96.3% |
| Q4 2015 | $254,000 | -3.8% | 2,950 | +2.6% | 0.03% | -10.0% |
| Q3 2015 | $264,000 | -25.6% | 2,875 | -20.4% | 0.03% | -21.1% |
| Q2 2015 | $355,000 | +1.1% | 3,614 | +1.6% | 0.04% | 0.0% |
| Q1 2015 | $351,000 | +3.5% | 3,558 | -2.7% | 0.04% | 0.0% |
| Q4 2014 | $339,000 | -30.2% | 3,658 | -29.2% | 0.04% | -34.5% |
| Q3 2014 | $486,000 | +12.0% | 5,168 | +7.8% | 0.06% | +7.4% |
| Q2 2014 | $434,000 | +77.1% | 4,795 | +66.6% | 0.05% | +54.3% |
| Q1 2014 | $245,000 | -55.0% | 2,878 | -57.6% | 0.04% | -16.7% |
| Q4 2013 | $544,000 | +114.2% | 6,780 | +104.3% | 0.04% | -4.5% |
| Q3 2013 | $254,000 | +13.4% | 3,318 | +4.7% | 0.04% | 0.0% |
| Q2 2013 | $224,000 | – | 3,169 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |